Search results
Results From The WOW.Com Content Network
The company posted quarterly revenue of $1.61 billion, beating analysts' average estimate of $1.57 billion. "In the United States, the Dobbs decision has driven an increase in demand from patients ...
Organon (OGN) delivered earnings and revenue surprises of 7.76% and 5.40%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
For premium support please call: 800-290-4726 more ways to reach us
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. [4] Organon specializes in the following core therapeutic fields: reproductive medicine , contraception , psychiatry , hormone replacement therapy (HRT), and anesthesia .
In 2007 Organon International was sold to Schering-Plough for €11 billion and AkzoNobel delisted its shares from the US NASDAQ stock market. In 2008 Crown Paints was sold in a management buyout. [13] In December 2012, AkzoNobel agrees to sell its North American Architectural Coatings business to PPG Industries for $1.1 billion. [14]
Organon goes public, stock falls in debut. June 3, 2021 at 12:40 PM ...
6 The Nasdaq first traded above 5,100 on March 10, 2000; however, it took over 15 years for the Nasdaq to finally close above 5,100. 7 This was the Nasdaq's all-time intraday high on March 10, 2000, which was finally broken on June 18, 2015. 8 This was the Nasdaq's close at the peak on July 20, 2015, before the 2015-16 stock market selloff.
For premium support please call: 800-290-4726 more ways to reach us